Trials / Terminated
TerminatedNCT02162979
Sildenafil (Viagra) for the Treatment of Dyskinesias in Parkinson's Disease
A Double-Blind, Placebo-Controlled, Cross-Over Study of Sildenafil (Viagra) for the Treatment of Dyskinesias in Parkinson's Disease
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- Loma Linda University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study is to determine if Viagra is effective in reducing dyskinesias in patients with Parkinson's Disease.
Detailed description
Inclusion Criteria: 1. Diagnosis of idiopathic Parkinson's disease. 2. Age \> 40 years. 3. willingness and ability to comply with the study requirements and give informed consent.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | sildenafil | sildenafil 50mg BID for 2 weeks |
| DRUG | Placebo |
Timeline
- Start date
- 2002-02-01
- Primary completion
- 2009-01-01
- Completion
- 2009-01-01
- First posted
- 2014-06-13
- Last updated
- 2018-03-30
- Results posted
- 2014-07-22
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02162979. Inclusion in this directory is not an endorsement.